Repligen (RGEN) Research & Development (2016 - 2025)
Historic Research & Development for Repligen (RGEN) over the last 16 years, with Q3 2025 value amounting to $14.2 million.
- Repligen's Research & Development rose 4598.35% to $14.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.7 million, marking a year-over-year increase of 2613.38%. This contributed to the annual value of $43.2 million for FY2024, which is 111.89% up from last year.
- As of Q3 2025, Repligen's Research & Development stood at $14.2 million, which was up 4598.35% from $14.0 million recorded in Q2 2025.
- Repligen's 5-year Research & Development high stood at $14.2 million for Q3 2025, and its period low was $7.6 million during Q1 2021.
- Its 5-year average for Research & Development is $10.8 million, with a median of $10.6 million in 2024.
- Per our database at Business Quant, Repligen's Research & Development skyrocketed by 10701.04% in 2021 and then crashed by 819.7% in 2024.
- Quarter analysis of 5 years shows Repligen's Research & Development stood at $9.1 million in 2021, then increased by 21.87% to $11.1 million in 2022, then fell by 7.45% to $10.3 million in 2023, then increased by 13.53% to $11.7 million in 2024, then increased by 21.39% to $14.2 million in 2025.
- Its Research & Development stands at $14.2 million for Q3 2025, versus $14.0 million for Q2 2025 and $12.9 million for Q1 2025.